Bowen's Disease Clinical Trial
Official title:
Long-term Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy for Treatment of Lower Extremity Bowen's Disease: A Prospective, Randomized, Controlled Trial With 5-year Follow up
Er:YAG ablative fractional laser-assisted methyl aminolevulinate photodynamic therapy (AFL-PDT) has shown significantly higher efficacy and a lower recurrence rate at 12 months than methyl aminolevulinate photodynamic therapy (MAL-PDT) for treatment of Bowen's disease (BD). However, long-term follow up data are not available.
To compare the long-term efficacy and recurrence rates of AFL-PDT and standard MAL-PDT for the treatment of lower extremity BD. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03012009 -
Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial
|
N/A | |
Completed |
NCT02085395 -
Clinical Study Assessment of SR-T100 Topical Gel Against Actinic Keratosis
|
Phase 2 | |
Recruiting |
NCT03909646 -
Surgical Excision Versus Photodynamic Therapy and Topical 5-fluorouracil in Treatment of Bowen's Disease
|
Phase 4 | |
Terminated |
NCT00472706 -
Trial of Excision Versus Photodynamic Therapy in the Treatment of Bowen's Disease
|
Phase 4 | |
Completed |
NCT04293679 -
Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With isSCC
|
Phase 1/Phase 2 | |
Completed |
NCT01912976 -
Study of Methyl Aminolaevulinate Photodynamic Therapy With and Without Er:YAG Laser in Bowen's Disease
|
Phase 1 | |
Active, not recruiting |
NCT06014697 -
OCT and Invasion in Cutaneous Skin Lesions
|
||
Completed |
NCT03167762 -
Photographing the Skin During Photodynamic Therapy
|
N/A | |
Recruiting |
NCT02759900 -
Using a Cold Atmospheric Plasma Device to Treat Skin Disorders
|
N/A | |
Recruiting |
NCT05402046 -
Clinical vAlidation of a MobilE appLication ("ProRodinki") in the Assessment of the maLignant skIn neoplAsms
|
N/A | |
No longer available |
NCT00535080 -
Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actinic Keratoses, Large/Multiple Superficial Basal Cell Carcinomas (BCCs), or Bowen's Disease
|